EPT Disclosure
May 16 2006 - 8:41AM
UK Regulatory
RNS Number:0500D
Deutsche Bank AG London
16 May 2006
FORM 38.5
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
(Rule 38.5 of the City Code on Takeovers and Mergers)
1. KEY INFORMATION
Name of exempt principal trader Deutsche Bank AG London
Company dealt in Cambridge Antibody Technology Group Plc
Class of relevant security to which the dealings Ordinary
being disclosed relate (Note 1)
Date of dealing 15/05/2006
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3)
847,019 #12.9945 #12.875
Total number of securities Sold Highest price received (Note 3) Lowest price received (Note 3)
10,814 #12.985 #12.92
(b) Derivatives transactions (other than options)
Product name, e.g. Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3)
CFD
CFD Long 55,520 #12.9129
CFD Long 22,008 #12.939593
CFD Long 90,759 #12.98187
CFD Long 270,267 #12.9875
CFD Long 100,000 #12.9945
CFD Long 49,685 #12.98
CFD Long 8,780 #12.939896
CFD Short 4,000 #12.955
CFD Short 1,540 #12.975
CFD Short 3,407 #12.9811
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name,e.g. Writing, Number of Exercise Type, e.g. Expiry Option money
call option selling, securities to price American, date paid/received
purchasing, which the option European etc. per unit (Note
varying etc. relates (Note 5) 3)
(ii) Exercising
Product name, e.g. call option Number of securities Exercise price per unit (Note 3)
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this should be
stated.
.....................................................................
.....................................................................
Date of disclosure 16/05/2006
Contact name Kelly-Jade Ledwich
Telephone number 0207 545 7804
Name of offeree/offeror with which connected AstraZeneca Plc
Nature of connection (Note 6) Advisor to the offeror
Notes
The Notes on Form 38.5 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMSFUFEMSMSEDI
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024
